Skip to content
PIL Logo

Calcort 6mg Tablets

Last Updated on eMC 07-Mar-2017 View document  | SANOFI Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07-Mar-2017 and displayed until Current

Reasons for adding or updating:

  • Change to section 6 - date of revision
  • Change to section 2 - interactions with other medicines, food or drink

Updated on 19-May-2015 and displayed until 07-Mar-2017

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision

Updated on 10-Jul-2014 and displayed until 19-May-2015

Reasons for adding or updating:

  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision

Updated on 19-Aug-2013 and displayed until 10-Jul-2014

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 31-Oct-2012 and displayed until 19-Aug-2013

Reasons for adding or updating:

  • Change to Marketing Authorisation Holder

Updated on 31-Oct-2012 and displayed until 31-Oct-2012

Reasons for adding or updating:

  • Change to Marketing Authorisation Holder

Updated on 20-Mar-2012 and displayed until 31-Oct-2012

Reasons for adding or updating:

  • Improved Electronic Presentation

Updated on 29-Jul-2009 and displayed until 20-Mar-2012

Reasons for adding or updating:

  • Change of inactive ingredient

Updated on 29-Jan-2009 and displayed until 29-Jul-2009

Reasons for adding or updating:

  • Change to Marketing Authorisation Holder

Updated on 26-Jan-2009 and displayed until 29-Jan-2009

Reasons for adding or updating:

  • PIL Submitted in error
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Company contact details

SANOFI

Company image
Address

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK

Fax

+44 (0)1483 535 432

Medical Information e-mail
Telephone

+44 (0)1483 505 515

Medical Information Direct Line

+44 (0)845 372 7101

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

deflazacort

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue